openPR Logo
Press release

Investigation announced for Investors in shares of Inotiv, Inc. (NASDAQ: NOTV)

06-03-2022 04:41 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in Inotiv, Inc. (NASDAQ: NOTV) shares over potential securities laws violations by Inotiv, Inc.

An investigation for investors in Inotiv, Inc. (NASDAQ: NOTV) shares over potential securities laws violations by Inotiv, Inc.

An investigation was announced concerning potential securities laws violations by Inotiv, Inc. in connection with certain financial statements.

Investors who purchased shares of Inotiv, Inc. (NASDAQ: NOTV), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Inotiv, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

West Lafayette, IN based Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. Inotiv, Inc reported that its Total Revenue rose from $60.46 million to $89.6 million for the 12 months period that ended on September 30, 2020, and that its Net Loss over those respective time periods increased from $1.49 million to $1.68 million.
According to Seeking Alpha, on May 23, 2022, it was disclosed that a DOJ-backed lawsuit was initiated against a subsidiary of Inotiv, Inc. The legal action is for alleged violations of animal welfare.

Shares of Inotiv, Inc (NASDAQ: NOTV) declined from $19.01 per share on May 18, 2022, to as low as $11.87 per share on May 23, 2022.

Those who purchased shares of Inotiv, Inc. (NASDAQ: NOTV) have certain options and should contact the Shareholders Foundation.

Contact:
Christopher Clausen
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in shares of Inotiv, Inc. (NASDAQ: NOTV) here

News-ID: 2644047 • Views:

More Releases from Shareholders Foundation

Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to recover losses
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements. Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover losses
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc.. Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Malvern, PA based Ocugen, Inc., a
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) should contact the Shareholders Foundation in connection with Lawsuit
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp. Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV
Investigation announced for Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL) over possible Violations of Securities Laws
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements. Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false

All 5 Releases


More Releases for Inotiv

Deadline on August 22nd coming up in Lawsuit for Investors in Inotiv, Inc. (NASD …
A deadline is coming up on August 22, 2022 in the lawsuit filed for certain investors of Inotiv, Inc. (NASDAQ: NOTV) over alleged securities laws violations by Inotiv, Inc. Investors who purchased shares of Inotiv, Inc. (NASDAQ: NOTV) have certain options and there are strict and short deadlines running. Deadline: August 22, 2022. NASDAQ: NOTV stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to the
Lawsuit filed for Investors in shares of Inotiv, Inc. (NASDAQ: NOTV)
An investor, who purchased shares of Inotiv, Inc. (NASDAQ: NOTV), filed a lawsuit over alleged Securities Laws violations by Inotiv, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Inotiv, Inc. (NASDAQ: NOTV) have certain options and for certain investors are short and strict deadlines running. Deadline: August 22, 2022. NASDAQ: NOTV investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -
Computational Predictive Toxicology Modeling Service Market Research New Report …
The Computational Predictive Toxicology Modeling Service market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge
Computational Predictive Toxicology Modeling Service Market Analysis by Size, De …
The "Computational Predictive Toxicology Modeling Service Market" research report is an intelligence report that has been meticulously compiled to find relevant and valuable information. The data studied is designed with the best existing players and future competitors. The key player's business strategies and new market industries are studied in detail. The report makes future forecasts based on an analysis of market fragmentation, including product categories, end-user applications and Computational Predictive
Computational Toxicology Solutions Market Analysis, Promising Growth Opportuniti …
Los Angeles, United States,- This research study is one of the most detailed and accurate ones that solely focus on the global Computational Toxicology Solutions market. It sheds light on critical factors that impact the growth of the global Computational Toxicology Solutions market on several fronts. Market participants can use the report to gain a sound understanding of the competitive landscape and strategies adopted by leading players of the global
Preclinical CRO Market Trends, Growth Analysis, Investigation by Regions, Types, …
The QY Research released a latest market research report on the Global Preclinical CRO market, which is segmented by region (country), company and by Application. Players, stakeholders, and other participants in the global Preclinical CRO market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country) and by Application of Global Preclinical CRO market. For More